BJP College Seminars Series
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, D. A.

The British Journal of Psychiatry 152: 320-323 (1988)
© 1988 The Royal College of Psychiatrists

The significance of depression in the prediction of relapse in chronic schizophrenia

DA Johnson
University Hospital of South Manchester.

The prospective monitoring of two separate groups of chronically schizophrenic patients on regular depot maintenance therapy suggests that depression developing after an interval of 1 year from recovery from an acute relapse indicates a significant increase in the risk of a further relapse within 2 years, compared with depression within the first year, or no depression. Patients with such depression were more prone to relapses than other patients, despite regular medication within normal dose ranges. The results suggest that the aetiology of depression occurring in patients after 1 year in a stable mental state is different from that of depression within the first year, and in many patients, the former represents underlying schizophrenic activity prior to an early relapse.


This article has been cited by other articles:


Home page
 Schizophr BullHome page
P. F. Buckley, B. J. Miller, D. S. Lehrer, and D. J. Castle
Psychiatric Comorbidities and Schizophrenia
Schizophr Bull, November 14, 2008; (2008) sbn135v1.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
S. G. Siris
Depression in Schizophrenia: Perspective in the Era of "Atypical" Antipsychotic Agents
Am J Psychiatry, September 1, 2000; 157(9): 1379 - 1389.
[Abstract] [Full Text]

Home page
 Am. J. PsychiatryHome page
S. Zisook, L. A. McAdams, J. Kuck, M. J. Harris, A. Bailey, T. L. Patterson, L. L. Judd, and D. V. Jeste
Depressive Symptoms in Schizophrenia
Am J Psychiatry, November 1, 1999; 156(11): 1736 - 1743.
[Abstract] [Full Text]

Home page
 Arch Gen PsychiatryHome page
G. D. Tollefson, T. M. Sanger, Y. Lu, and M. E. Thieme
Depressive Signs and Symptoms in Schizophrenia: A Prospective Blinded Trial of Olanzapine and Haloperidol
Arch Gen Psychiatry, March 1, 1998; 55(3): 250 - 258.
[Abstract] [Full Text] [PDF]

Home page
 J Am Psychiatr Nurses AssocHome page
K. H. Littrell and S. H. Littrell
Therapeutic Efficacy of Olanzapine
Journal of the American Psychiatric Nurses Association, February 1, 1997; 3(1): S8 - S13.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.